Downregulation of glutathione peroxidase 3 is associated with lymph node metastasis and prognosis in cervical cancer

Xianglan Zhang, Zhenlong Zheng, Shen Yingji, Hyeyeon Kim, Renshun Jin, Li Renshu, Doo Young Lee, MiRyung Roh, Sanghwa Yang

Research output: Contribution to journalArticle

20 Citations (Scopus)

Abstract

Glutathione peroxidase 3 (GPX3) is a member of the glutathione peroxidase family of selenoproteins and is one of the key defensive enzymes against oxidative damages to host cells. Downregulation of GPX3 due to its promoter hypermethylation has been documented in several different types of cancer, indicating that GPX3 functions as a possible tumor suppressor. In the present study, we showed that GPX3 is also significantly downregulated in cervical cancer tissues compared to normal cervical tissues by qRT-PCR analyses and immunohistostainings. GPX3 expression was significantly related to lymph node metastasis and prognosis in cervical cancer patients. Treatment of cervical cancer cells with 5-aza-2′-deoxycytidine restored the expression of GPX3 and methylation-specific PCR (MSP) confirmed the CpG methylation of the GPX3 gene. Our results indicate that promoter methylation is one of the major causes of GPX3 downregulation in cervical cancer and GPX3 could serve as a predictive biomarker for lymph node metastasis and prognosis of cervical cancer.

Original languageEnglish
Pages (from-to)2587-2592
Number of pages6
JournalOncology Reports
Volume31
Issue number6
DOIs
Publication statusPublished - 2014 Jan 1

Fingerprint

Glutathione Peroxidase
Uterine Cervical Neoplasms
Down-Regulation
Lymph Nodes
Neoplasm Metastasis
Methylation
decitabine
Selenoproteins
Polymerase Chain Reaction
Neoplasms
Biomarkers
Enzymes

All Science Journal Classification (ASJC) codes

  • Oncology
  • Cancer Research

Cite this

Zhang, Xianglan ; Zheng, Zhenlong ; Yingji, Shen ; Kim, Hyeyeon ; Jin, Renshun ; Renshu, Li ; Lee, Doo Young ; Roh, MiRyung ; Yang, Sanghwa. / Downregulation of glutathione peroxidase 3 is associated with lymph node metastasis and prognosis in cervical cancer. In: Oncology Reports. 2014 ; Vol. 31, No. 6. pp. 2587-2592.
@article{41fe01127b8e49ed97a915ca4ef575d7,
title = "Downregulation of glutathione peroxidase 3 is associated with lymph node metastasis and prognosis in cervical cancer",
abstract = "Glutathione peroxidase 3 (GPX3) is a member of the glutathione peroxidase family of selenoproteins and is one of the key defensive enzymes against oxidative damages to host cells. Downregulation of GPX3 due to its promoter hypermethylation has been documented in several different types of cancer, indicating that GPX3 functions as a possible tumor suppressor. In the present study, we showed that GPX3 is also significantly downregulated in cervical cancer tissues compared to normal cervical tissues by qRT-PCR analyses and immunohistostainings. GPX3 expression was significantly related to lymph node metastasis and prognosis in cervical cancer patients. Treatment of cervical cancer cells with 5-aza-2′-deoxycytidine restored the expression of GPX3 and methylation-specific PCR (MSP) confirmed the CpG methylation of the GPX3 gene. Our results indicate that promoter methylation is one of the major causes of GPX3 downregulation in cervical cancer and GPX3 could serve as a predictive biomarker for lymph node metastasis and prognosis of cervical cancer.",
author = "Xianglan Zhang and Zhenlong Zheng and Shen Yingji and Hyeyeon Kim and Renshun Jin and Li Renshu and Lee, {Doo Young} and MiRyung Roh and Sanghwa Yang",
year = "2014",
month = "1",
day = "1",
doi = "10.3892/or.2014.3152",
language = "English",
volume = "31",
pages = "2587--2592",
journal = "Oncology Reports",
issn = "1021-335X",
publisher = "Spandidos Publications",
number = "6",

}

Zhang, X, Zheng, Z, Yingji, S, Kim, H, Jin, R, Renshu, L, Lee, DY, Roh, M & Yang, S 2014, 'Downregulation of glutathione peroxidase 3 is associated with lymph node metastasis and prognosis in cervical cancer', Oncology Reports, vol. 31, no. 6, pp. 2587-2592. https://doi.org/10.3892/or.2014.3152

Downregulation of glutathione peroxidase 3 is associated with lymph node metastasis and prognosis in cervical cancer. / Zhang, Xianglan; Zheng, Zhenlong; Yingji, Shen; Kim, Hyeyeon; Jin, Renshun; Renshu, Li; Lee, Doo Young; Roh, MiRyung; Yang, Sanghwa.

In: Oncology Reports, Vol. 31, No. 6, 01.01.2014, p. 2587-2592.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Downregulation of glutathione peroxidase 3 is associated with lymph node metastasis and prognosis in cervical cancer

AU - Zhang, Xianglan

AU - Zheng, Zhenlong

AU - Yingji, Shen

AU - Kim, Hyeyeon

AU - Jin, Renshun

AU - Renshu, Li

AU - Lee, Doo Young

AU - Roh, MiRyung

AU - Yang, Sanghwa

PY - 2014/1/1

Y1 - 2014/1/1

N2 - Glutathione peroxidase 3 (GPX3) is a member of the glutathione peroxidase family of selenoproteins and is one of the key defensive enzymes against oxidative damages to host cells. Downregulation of GPX3 due to its promoter hypermethylation has been documented in several different types of cancer, indicating that GPX3 functions as a possible tumor suppressor. In the present study, we showed that GPX3 is also significantly downregulated in cervical cancer tissues compared to normal cervical tissues by qRT-PCR analyses and immunohistostainings. GPX3 expression was significantly related to lymph node metastasis and prognosis in cervical cancer patients. Treatment of cervical cancer cells with 5-aza-2′-deoxycytidine restored the expression of GPX3 and methylation-specific PCR (MSP) confirmed the CpG methylation of the GPX3 gene. Our results indicate that promoter methylation is one of the major causes of GPX3 downregulation in cervical cancer and GPX3 could serve as a predictive biomarker for lymph node metastasis and prognosis of cervical cancer.

AB - Glutathione peroxidase 3 (GPX3) is a member of the glutathione peroxidase family of selenoproteins and is one of the key defensive enzymes against oxidative damages to host cells. Downregulation of GPX3 due to its promoter hypermethylation has been documented in several different types of cancer, indicating that GPX3 functions as a possible tumor suppressor. In the present study, we showed that GPX3 is also significantly downregulated in cervical cancer tissues compared to normal cervical tissues by qRT-PCR analyses and immunohistostainings. GPX3 expression was significantly related to lymph node metastasis and prognosis in cervical cancer patients. Treatment of cervical cancer cells with 5-aza-2′-deoxycytidine restored the expression of GPX3 and methylation-specific PCR (MSP) confirmed the CpG methylation of the GPX3 gene. Our results indicate that promoter methylation is one of the major causes of GPX3 downregulation in cervical cancer and GPX3 could serve as a predictive biomarker for lymph node metastasis and prognosis of cervical cancer.

UR - http://www.scopus.com/inward/record.url?scp=84902159529&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84902159529&partnerID=8YFLogxK

U2 - 10.3892/or.2014.3152

DO - 10.3892/or.2014.3152

M3 - Article

VL - 31

SP - 2587

EP - 2592

JO - Oncology Reports

JF - Oncology Reports

SN - 1021-335X

IS - 6

ER -